TransCode Therapeutics Price Chart
TransCode Therapeutics Volume Chart
TransCode Therapeutics Market Segments
Regular Trading Hours
-0.15(-1.60%)
| Open | $9.36 |
|---|---|
| Close | $9.21 |
| Low | $9.20 |
| Low Change | -0.16 (-1.71%) |
| High | $9.75 |
| High Change | +0.39 (+4.17%) |
| Range | $0.55 |
| Volume | 2.676K |
| Dollar Volume | $24.65K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $9.50 |
|---|---|
| Close | $9.50 |
| Low | $9.50 |
| Low Change | 0.00 (0.00%) |
| High | $9.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $950.00 |
Regular Trading Hours Yesterday
-0.13(-1.37%)
| Open | $9.48 |
|---|---|
| Close | $9.35 |
| Low | $9.32 |
| Low Change | -0.17 (-1.74%) |
| High | $9.80 |
| High Change | +0.32 (+3.38%) |
| Range | $0.49 |
| Volume | 9.22K |
| Dollar Volume | $86.21K |
Premarket Yesterday
*No Trades in Segment
TransCode Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $9.63 |
|---|---|
| 10 Day Moving Average (SMA10) | $9.72 |
| 20 Day Moving Average (SMA20) | $9.73 |
| 50 Day Moving Average (SMA50) | $9.44 |
| 100 Day Moving Average (SMA100) | $9.46 |
| 200 Day Moving Average (SMA200) | $9.73 |
TransCode Therapeutics Statistics
| Average Volume (30 Days) | 415.59K |
|---|---|
| P/E Ratio (Current) | -.33 |
| EPS (Current) | -$29.62 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$14.52M |
| Cash Ratio | 0.96 |
| Current Ratio | 1.60 |
| Quick Ratio | 1.60 |
| Debt to Equity | 0.00 |
| Enterprise Value | $6.14M |
| EV to EBITDA | -0.36 |
| EV to Sales | — |
| Price to Book | 6.30 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -5.20% |
| Return on Equity | -19.05% |
TransCode Therapeutics Stock Splits
There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.
| Date | Type | Ratio |
|---|---|---|
| May 15, 2025 | Reverse | 28:1 |
| Dec 4, 2024 | Reverse | 33:1 |
| Jan 16, 2024 | Reverse | 40:1 |
| May 23, 2023 | Reverse | 20:1 |
TransCode Therapeutics Dividends
There have been no dividends for TransCode Therapeutics (RNAZ).